Flublok Quadrivalent Northern Hemisphere
Product Images NDC 49281-723

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Flublok Quadrivalent Northern Hemisphere (NDC 49281-723). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Pasteur Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Principal Display Panel (0.5 mL Syringe Label)
This is a description of a flu vaccine called FLUBLOK® Quad, with the 2022/2023 formula and no preservative. It is a single-dose vaccine for intramuscular injection, manufactured by Protein Sciences Corp. The NDC code for the vaccine is 492-88 and the lot and expiry information are reserved in an area that takes up 4% of the label.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

Principal Display Panel (0.5 mL Syringe Carton)
FLUBLOK Quadrivalent is a flu vaccine consisting of four components that are injected intramuscularly. The vaccine comes in prefilled syringes and is intended for those aged 18 years or older. The vaccine has to be stored in a refrigerated temperature range of 2°C to 8°C (36°F to 41°F) and should not be frozen. The label warns not to use the vaccine if it has been frozen. Each 0.5 mL dose of the vaccine contains four different subtypes of the influenza virus derived from the Wisconsin/588/2019 (HIN), Darwin/6/2021 (H3N2), Austria/1359417/2021, and Phuket/3073/2013 viruses. The recombinant HAs used to produce the vaccine are grown in cultured cells and combined with a phosphate buffer saline and polysorbate 20(Tween 20). The tip caps and plungers on the prefilled syringes are free from natural rubber latex. The text also provides the NDC code for the vaccine.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Principal Display Panel (0.5 mL Syringe Label)
This is a description of an influenza vaccine called FLUBLOK® Quadrivalent. The package contains a single-dose (0.5 mL) vaccine, without preservatives. It is intended for intramuscular injection and was manufactured by Protein Sciences Corp. Unfortunately, the expiration date, lot number, and some parts of the text are not available due to errors.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

Principal Display Panel (0.5 mL Syringe Carton)
This text appears to be a product description of a flu vaccine called FLUBLOK Quadrivalent, with details on recommended storage conditions, ingredients, and dosage. It also includes a warning not to freeze the product and to discard it if frozen. The vaccine is a recombinant protein produced in cultured cells and is formulated with a buffered saline solution and polysorbate 20. The product is described as containing no preservatives and is intended for intramuscular administration only. The text also mentions that the prefilled syringes do not contain natural rubber latex. There are references to various influenza virus strains included in the vaccine, their origins, and the method of production. The document also includes information on the manufacturer, expiration, and product identification codes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.